You are here

Article Text

Article menu
Download PDFPDF
Letters
PostScript
Is the coprescription of β blockers and β2 agonists justified in COPD?
  1. A Singh
  1. Dr A Singh, Department of Pulmonary Medicine, Christian Medical College and Hospital, Ludhiana 141010, India; drsinghakashdeep{at}gmail.com

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Dransfield and colleagues1 advocate the use of β blockers even in patients admitted with acute exacerbations of chronic obstructive pulmonary disease (COPD), but certain points need further discussion.

    Their retrospective analysis highlights the discordance in practice that exists between cardiologist and pulmonologist. Indeed, the former is keen to commence β blockers in patients with a wide range of cardiovascular diseases …

    View Full Text

    Linked Articles

    • Letters
      Authors’ response
      M T Dransfield S M Rowe J Johnson W Bailey L Gerald
      Thorax 2008; 63 1026-1026 Published Online First: 04 Nov 2008.
    • Letters
      Authors’ response
      M T Dransfield S M Rowe J Johnson W Bailey L Gerald
      Thorax 2008; 63 1027-1027 Published Online First: 04 Nov 2008.